PMFLIST Archives

July 2020


Options: Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Kristen Peters <[log in to unmask]>
Reply To:
The Pharmaceutical Microbiology Forum Email List <[log in to unmask]>
Mon, 20 Jul 2020 11:25:47 -0400
text/plain (53 lines)
All - does anyone know what the USP recommends if the suitability test
fails using neutralizing agents? What is the next step, can we proceed with
the PET/AET on the product?

Kristen Peters
General Manager
Advanced Laboratories, Inc. North Carolina
919-989-7793 <(919)%20989-7793> (NC Lab, FDA Reg #10560615298)
919-989-9226 <(919)%20989-9226>(Fax)

*If you liked our service, please tell a friend.  If you didn’t, please
tell us!*

ISO/IEC 17025:2017 Accredited  |   UT Lab FDA Registration # 14353128308  |
NC Lab FDA Registration # 10560615298


The information contained in this e-mail correspondence is intended solely
for the use of the individual or entity to which it is addressed, and may
contain information that is PRIVILEGED and CONFIDENTIAL. If you are not the
intended recipient, you are hereby notified that any disclosure,
duplication, distribution or the taking of any action in reliance upon this
correspondence is strictly prohibited. If you received this correspondence
in error, please notify the sender by phone, fax, or e-mail and destroy any
and all copies of the correspondence. Thank you.

The PMFList is supported by our sponsors as a service to the scientific community.

Please take a second to visit our sponsors' web sites and say thank you for their support of this service.
If your company would be interested in sponsoring this community, please contact [log in to unmask]

Steris -

Charles River Laboratories -

Veltek Associates, Inc -

Microbiologics, Inc. -

BD Industrial Media -

Associates of Cape Cod, Inc. -

The nature of this service is to provide a medium for communication.  The specific statements and endorsements of individuals participating in the discussions are not necessarily those of the PMF or the sponsors of the list.